infect
known
newli
emerg
rna
virus
hepat
c
viru
hcv
ebola
viru
influenza
viru
sarscov
sever
threat
public
health
rna
virus
caus
injuri
infect
organ
disrupt
normal
function
lead
high
level
morbid
mortal
rna
virus
exhibit
genom
hypervari
mainli
caus
low
fidel
virusderiv
rnadepend
rna
polymeras
activ
instabl
rna
viral
genom
allow
virus
escap
virusspecif
drug
vaccin
develop
stabl
vaccin
rna
virus
challeng
task
altern
tool
modul
immun
respons
viral
infect
great
interest
among
ifnbas
therapi
show
strong
potenti
hcv
clearanc
stimul
innat
adapt
immun
system
infect
host
although
ifn
resist
often
report
hcvinfect
patient
concept
ifnbas
therapi
viru
erad
prompt
explor
therapeut
agent
target
innat
immun
system
infect
host
regard
synthet
agonist
tolllik
receptor
tlr
success
develop
potent
ifninduc
potenti
control
viral
replic
infectionrel
diseas
extens
studi
earli
detect
viru
infect
host
reli
specif
receptor
recogn
virusderiv
molecular
pattern
doubl
strand
rna
dsrna
strand
rna
ssrna
local
membran
endosom
compart
sens
nonself
molecular
pattern
deriv
viral
particl
contrast
retino
acidinduc
gene
rigi
melanoma
differentiationassoci
gene
five
detect
molecular
pattern
deriv
replic
rna
virus
cytoplasm
upon
recognit
intracellular
nonself
rna
rigi
protein
recruit
mitochondria
via
associ
cardif
also
call
visa
mav
trigger
product
signal
activ
although
rigi
util
signal
pathway
product
exhibit
differenti
prefer
toward
rna
substrat
therefor
detect
differ
type
virus
suggest
rna
structur
moieti
found
replic
ssrna
virus
hcv
newcastl
diseas
viru
ndv
respiratori
syncyti
viru
rsv
influenza
viru
structur
select
recogn
rigi
meanwhil
preferenti
detect
long
stretch
dsrna
structur
mainli
produc
replic
encephalomyocard
viru
emcv
reoviru
signific
viral
recognit
signal
cascad
mediat
cytosol
rigi
well
demonstr
vivo
use
rigi
knockout
mice
mice
exhibit
defect
immun
respons
ndv
sendai
viru
sev
vesicular
stomat
viru
vsv
infect
wherea
mice
exhibit
specif
defect
emcv
infect
aptam
singlestrand
nucleic
acid
molecul
select
selex
systemat
evolut
ligand
exponenti
enrich
technolog
base
affin
specif
target
protein
due
rapid
select
process
high
stabil
rel
low
immunogen
aptam
becom
favorit
choic
among
molecular
detect
tool
replac
use
antibodi
furthermor
depend
mode
action
aptam
capabl
modul
activ
target
molecul
facilit
develop
aptam
therapeut
purpos
aptam
antivir
activ
develop
virusspecif
protein
tat
hiv
hcv
less
effort
focus
aptam
target
innat
immun
respons
viral
infect
attempt
develop
aptam
specif
control
rigimedi
antivir
respons
infect
host
cell
screen
rna
oligonucleotid
specif
rigi
use
advancedselex
technolog
cell
maintain
minimum
essenti
medium
mem
contain
fetal
bovin
serum
fb
hyclon
logan
ut
usa
penicillinstreptomycin
gibco
cell
cell
maintain
dulbecco
modifi
eagl
medium
dmem
fb
antibiot
ndvgfp
vsvgfp
influenza
strain
gfp
kindli
provid
dr
peter
pales
mount
sinai
school
medicin
usa
dr
adolfo
garciasastr
mount
sinai
school
medicin
usa
respect
transfect
dna
plasmid
rna
oligonucleotid
includ
aptam
lipofectamin
invitrogen
use
polyi
c
purchas
r
system
amersham
bioscienc
respect
synthet
separ
synthes
anneal
follow
method
describ
secret
rant
human
elisa
develop
kit
r
system
human
rant
elisa
kit
thermo
scientif
use
respect
piresluc
stratagen
stratagen
plasmid
purchas
pprdiiiiluc
plasmid
provid
dr
katherin
fitzgerald
univers
massachusett
pefbosflagrigi
provid
dr
takashi
fujita
institut
viru
research
kyoto
univers
construct
pefbosflaghelicaserd
pefbosflagcard
plasmid
describ
previous
subclon
use
follow
primer
kindli
provid
dr
zhijian
j
chen
univers
texa
southwestern
medic
center
subsequ
subclon
xhoixbai
site
plasmid
dna
fragment
encod
human
rigi
amino
acid
sub
clone
express
vector
deriv
pfastbac
plasmid
invitrogen
vector
design
express
rigi
fusion
protein
contain
gst
nterminu
recombin
protein
produc
insect
cell
base
baculoviru
express
vector
system
harvest
cell
resuspend
lyse
sonic
lysi
buffer
consist
mm
tri
ph
mm
nacl
mm
dithiothreitol
supernat
cell
lysat
load
onto
column
pack
gst
bind
resin
novagen
elut
buffer
contain
mm
reduc
glutathion
purifi
flagrigi
flaghelicaserd
amino
acid
flagcard
amino
acid
protein
plsi
novagen
bacteria
human
rigi
gene
sub
clone
express
vector
deriv
pproex
hta
invitrogen
cpd
plasmid
bacteria
cell
cultur
lb
broth
induc
overnight
iptg
cell
resuspend
lyse
sonic
lysi
buffer
consist
mm
tri
ph
nacl
mm
supernat
load
onto
column
pack
cobalt
resin
novagen
elut
mm
tri
ph
mm
nacl
mm
mm
imidazol
cpd
cleav
tev
proteas
phytat
remov
rigi
helicaserd
card
use
cobalt
resin
subsequ
hitrap
q
hiload
superdex
column
ge
healthcar
use
purif
protein
follow
primer
use
clone
rigi
mutant
flagrigi
flaghelicaserd
flagcard
synthet
dna
librari
pool
cataaccc
amplifi
pcr
use
follow
primer
prepar
rna
oligonucleotid
pcr
product
vitro
transcrib
use
transcript
kit
contain
epicentr
biotechnolog
h
follow
purif
column
first
selex
cycl
nmol
rna
oligonucleotid
pool
incub
pmol
biotinyl
human
rigi
protein
min
pb
mm
oligonucleotid
bound
rigi
harvest
use
biotinstreptavidin
system
sigma
revers
transcrib
pcr
amplifi
concentr
rna
oligonucleotid
pool
rigi
protein
gradual
reduc
next
round
aptam
select
cycl
selex
sequenc
select
clone
analyz
use
autom
dna
sequenc
remov
vitrotranscrib
rna
transcript
incub
u
alkalin
phosphat
neb
u
rnase
inhibitor
promega
h
cell
transfect
pprdiiii
pisr
togeth
prlcmv
h
stimul
cell
transfect
cognat
ligand
lipofectamin
use
dualluciferas
assay
kit
promega
firefli
luciferas
activ
measur
normal
valu
renilla
activ
rel
activ
fold
rel
mocktreat
sampl
use
total
rna
revers
transcrib
use
impromii
revers
transcript
system
promega
detect
ndvgfp
vsvgfp
random
oligom
use
revers
transcript
pcr
sybr
premix
extaq
takara
use
valu
obtain
use
realtim
pcr
system
appli
biosystem
data
normal
follow
primer
use
rant
gfp
cell
transfect
appropri
sirna
use
lipofectamin
follow
sequenc
use
sicontrol
sirigi
qiagen
valid
sirna
sicontrol
sirigi
synthes
custom
design
servic
qiagen
western
blot
analysi
antibodi
gfp
santacruz
rigi
alexi
biochem
prosci
incorpor
flag
sigma
cmyc
roch
gapdh
chemicon
santacruz
use
immunoreact
signal
develop
use
luminesc
imag
analyz
fujifilm
detect
intracellular
local
cell
coverglass
stimul
polyi
c
aptam
pmol
h
fix
paraformaldehyd
permeabil
solut
cell
incub
antibodi
santacruz
pb
contain
room
temperatur
h
cell
incub
antirabbit
igg
conjug
alexa
fluor
invitrogen
hoechst
sigma
slide
mount
analyz
use
olympu
fluoresc
microscop
radioactivelabel
aptam
product
aptam
vitro
transcrib
use
transcript
kit
mixtur
mm
gtp
hour
endlabel
pmole
aptreat
aptam
incub
polynucleotid
kinas
u
new
england
biolab
beverli
usa
pmol
min
label
aptam
subsequ
purifi
chroma
column
clontech
bind
assay
recombin
protein
total
lysat
mg
cell
incub
pmol
label
aptam
flag
antibodi
protein
g
plusprotein
aagaros
bead
calbiochem
hour
bound
rigi
fraction
quantit
use
liquid
scintil
analyz
lsa
screen
rigi
aptam
librari
pool
random
rna
oligonucleotid
use
purifi
fulllength
human
rigi
protein
figur
rna
oligonucleotid
bound
rigi
harvest
revers
transcrib
pcr
amplifi
transcrib
vitro
gener
rna
olibonucleotid
pool
next
round
select
supplementari
figur
cycl
select
amplif
independ
clone
rigi
aptam
uniqu
sequenc
obtain
sequenc
analysi
clone
indic
sequenc
select
rigi
aptam
contain
high
u
content
averag
repeat
polyun
motif
second
half
sequenc
figur
among
individu
aptam
clone
length
repeat
polyun
vari
n
n
figur
chose
eight
independ
rigi
aptam
clone
random
examin
vitro
bind
affin
purifi
rigi
protein
purpos
individu
rigi
aptam
endlabel
incub
purifi
fulllength
rigi
protein
absenc
presenc
trna
competitor
nonspecif
bind
figur
despit
differ
bind
potenti
test
rigi
aptam
exhibit
strong
rigi
bind
abil
compar
control
rna
librari
attempt
measur
vitro
bind
affin
select
aptam
estim
bound
free
form
label
aptam
equilibrium
condit
use
differ
amount
rigi
protein
purpos
pick
show
rel
weak
bind
compar
clone
henc
provid
lower
bound
valu
select
aptam
vitro
bmax
kd
valu
fmolmg
nm
respect
supplementari
figur
rna
aptam
prepar
vitro
use
rna
polymeras
result
moieti
first
nucleotid
posit
remain
moieti
ssrna
known
recogn
rigi
possibl
rna
aptam
directli
act
ligand
rigi
protein
test
possibl
vitro
bind
affin
nativ
alkalin
phosphatas
ap
treat
aptam
rigi
directli
compar
figur
everi
aptam
test
bind
aptam
rigi
protein
significantli
alter
presenc
moieti
indic
select
aptam
sequenc
govern
specif
bind
rigi
protein
determin
whether
rigi
aptam
abl
modul
rigimedi
product
stimul
cell
nativ
aptreat
rna
aptam
measur
promot
activ
use
prdiiiiluc
report
cell
express
fair
amount
endogen
rigi
protein
therefor
suitabl
test
regulatori
effect
rigi
aptam
everi
test
aptam
elicit
stimulatori
effect
promot
prdiiii
figur
signific
differ
nativ
aptreat
aptam
except
efficaci
remov
ap
separ
test
use
chemic
synthes
dsrna
figur
report
activ
induc
significantli
reduc
ap
treatment
indic
ap
effici
remov
moieti
examin
whether
regulatori
effect
screen
aptam
depend
rigi
function
cell
transfect
rigi
sirna
aptam
treatment
abil
rigi
aptam
stimul
promot
activ
significantli
impair
rigi
express
reduc
figur
function
knockdown
separ
confirm
polyi
c
stimul
cell
supplementari
figur
signal
activ
rigi
aptam
compar
convent
ligand
rigi
polyi
c
figur
stimul
cell
induc
promot
activ
rigi
overexpress
huh
human
hepatoma
cell
contrast
exhibit
moder
level
promot
activ
cell
activ
enhanc
rigi
overexpress
figur
depend
length
polyi
c
report
activ
rigi
differenti
long
kb
strand
polyi
c
bind
short
kb
strand
polyi
c
preferenti
activ
rigi
exhibit
similar
level
signal
activ
rel
long
form
polyi
c
higher
activ
rnaseiiidigest
short
form
polyi
c
figur
supplementari
figur
next
examin
whether
rigi
aptam
activ
signal
pathway
product
treat
induc
nuclear
transloc
transcript
factor
occupi
promot
figur
stimul
transactiv
activ
figur
result
mrna
express
rant
dramat
enhanc
figur
protein
level
rant
separ
confirm
condit
figur
result
indic
rna
aptam
specif
bind
potenti
rigi
protein
stimul
signal
pathway
rigidepend
yet
manner
identifi
key
regulatori
featur
respons
rigi
activ
construct
variou
mutant
measur
effect
express
mrna
figur
everi
rna
oligonucleotid
select
rigi
aptam
harbor
common
tail
use
revers
transcript
amplif
step
selex
screen
see
materi
method
section
therefor
first
evalu
contribut
common
tail
delet
mutat
common
tail
flank
polyu
motif
alter
stimulatori
effect
product
figur
addit
delet
common
tail
deterior
figur
base
substitut
predict
stemloop
structur
sl
supplementari
figur
effect
express
contrast
long
stretch
polyu
motif
critic
activ
produc
partial
substitut
consecut
u
almost
complet
abolish
activ
figur
furthermor
complet
substitut
polyu
motif
poli
c
g
pa
pc
pg
impair
activ
induc
mrna
express
figur
interestingli
rel
posit
polyu
motif
within
aptam
critic
ipu
mutant
contain
nucleotid
composit
intern
polyu
motif
induc
less
mrna
express
compar
wt
figur
result
clearli
indic
polyu
motif
within
aptam
sequenc
play
critic
role
activ
rigimedi
product
investig
whether
signal
activ
select
aptam
depend
bind
abil
rigi
protein
evalu
bind
potenti
mutant
aptam
purifi
rigi
protein
gener
signal
activ
mutant
aptam
produc
posit
correl
vitro
rigi
bind
except
mutant
figur
e
although
mutant
fail
activ
product
exhibit
compar
level
rigi
bind
data
suggest
rigi
aptam
might
act
convent
ligand
rigi
function
stabil
conform
rigi
activ
state
final
examin
product
activ
synthes
figur
signal
activ
complet
abolish
convent
nucleotid
use
instead
suggest
uniqu
structur
featur
rigi
activ
next
examin
bind
domain
rigi
aptam
purpos
mutant
form
rigi
overexpress
cell
bind
immunoprecipit
rigi
protein
measur
figur
b
present
immunoprecipit
flagrigi
complex
bind
significantli
diminish
immunocomplex
flagcard
contrast
found
immunocomplex
flaghelicaserd
contain
helicas
domain
well
carboxyltermin
rd
domain
direct
bind
mutant
form
rigi
separ
confirm
use
bacteri
purifi
recombin
protein
vitro
figur
although
data
indic
bind
directli
ctermin
rd
helicas
domain
rigi
aptam
bind
suffici
activ
rigimedi
signal
activ
none
rigi
mutant
abl
transmit
aptamerspecif
signal
activ
figur
data
indic
requir
intact
form
rigi
elicit
signal
activ
function
manner
wonder
whether
provid
moieti
tran
enhanc
signal
activ
test
idea
signal
activ
absenc
presenc
examin
rigi
overexpress
cell
figur
howev
addit
effect
observ
indic
bind
suffici
provid
conform
chang
rigi
full
activ
rigidepend
activ
express
key
step
trigger
antivir
respons
foreign
rna
virus
influenza
viru
ndv
vsv
hcv
therefor
evalu
whether
rigi
aptam
potenti
inhibit
replic
infect
rna
virus
cell
infect
either
ndvgfp
vsvgfp
contain
gene
code
green
fluoresc
protein
gfp
viral
genom
supplementari
figur
evalu
therapeut
potenti
cell
treat
h
viru
infect
viral
replic
assay
h
later
figur
contrast
rna
librari
pool
use
neg
control
treatment
effici
block
replic
ndv
vsv
figur
c
similar
effect
repress
influenza
strain
gfp
replic
also
demonstr
cell
treat
figur
examin
whether
pretreat
cell
prior
viral
infect
prevent
effect
figur
ndv
replic
almost
complet
block
cell
treat
h
infect
visual
fluoresc
gfp
figur
c
pcr
viru
specif
primer
figur
effici
induct
mrna
separ
verifi
figur
result
suggest
rigi
aptam
strong
potenti
inhibit
viral
replic
via
activ
rigi
product
rigi
dexhd
rna
helicas
sens
intracellular
nonself
rna
structur
deriv
infect
rna
virus
articl
report
identif
rigispecif
rna
aptam
antivir
potenti
select
rigi
aptam
behav
strong
agonist
rigi
determin
tendenc
activ
rigimedi
signal
pathway
depend
express
rigi
result
rigi
aptam
effici
block
replic
rna
viru
infect
cell
suggest
strong
potenti
therapeut
applic
origin
identifi
cytosol
receptor
nonself
rna
rigi
monitor
uniqu
rna
structur
cytoplasm
bind
dsrna
moieti
via
carboxyltermin
rd
domain
rigi
doublestrand
rna
intermedi
length
bp
bluntend
short
dsrna
bp
also
known
recogn
rigi
although
lack
moieti
rigi
tend
prefer
dsrna
ssrna
moieti
fail
activ
rigi
contrast
convent
ligand
rigi
select
rigi
aptam
seem
util
distinct
bind
strategi
moieti
aptam
requir
bind
rigi
yet
helicas
ctermin
rd
domain
rigi
essenti
bind
report
selftempl
copyback
activ
rna
polymeras
gener
doublestrand
rna
wonder
whether
vitro
transcrib
rigi
aptam
form
dsrna
structur
evalu
size
transcrib
rigi
denatur
polyacrylamid
gel
vitro
transcrib
rigi
aptam
migrat
posit
match
size
singlestrand
rigi
aptam
supplementari
figur
addit
stimul
potenti
rigimedi
signal
activ
strictli
depend
polyu
motif
posit
within
aptam
figur
rather
physic
bind
rigi
suggest
uniqu
featur
deriv
select
aptam
play
import
role
activ
rigi
noteworthi
mention
unanchor
chain
report
act
potent
ligand
rigi
therebi
suggest
anoth
class
rigi
ligand
function
nonconvent
manner
studi
show
rigi
aptam
bind
rdcontain
helicas
domain
rigi
stimul
rigidepend
signal
manner
specif
polyu
motif
found
near
side
rigi
aptam
essenti
activ
rigi
polyu
motif
somewhat
reminisc
polyuuc
rna
replic
hcv
identifi
strong
ligand
rigi
howev
coupl
differ
exist
two
motif
first
polyaga
show
compar
activ
polyuuc
hcv
genom
product
replac
u
polya
almost
complet
block
express
second
rigi
activ
signal
polyuuc
hcv
genom
diminish
use
instead
howev
vitrosynthes
exhibit
much
stronger
activ
transcript
gener
noteworthi
mention
rna
aptam
synthes
exhibit
increas
rna
stabil
compar
due
resist
nucleas
digest
final
polyuuc
hcv
report
lose
activ
page
purif
vitrosynthes
keep
activ
purif
procedur
data
indic
rigi
activ
rigi
aptam
quit
distinct
polyuuc
sequenc
deriv
hcv
rna
genom
propos
rigi
aptam
potenti
tool
base
abil
enhanc
product
block
viral
replic
due
immunecellrestrict
express
pattern
tolllik
receptor
tlr
famili
member
local
surfac
membran
reagent
target
protein
activ
screen
treatment
viral
infect
inflammationrel
diseas
contrast
rigi
mainli
express
nonimmun
cell
local
cytoplasm
present
technic
difficulti
associ
intracellular
deliveri
target
agent
furthermor
rigi
mainli
express
fibroblast
epitheli
cell
hepatocyt
convent
dendrit
cell
cdc
express
low
level
tlr
suggest
reagent
target
tlr
may
ideal
system
applic
instead
local
applic
rigi
aptam
infect
site
may
present
attract
altern
exampl
local
inject
rigi
aptam
olfactori
airway
epitheli
cell
may
effect
treatment
human
metapneumoviru
hmpv
respiratori
syncyti
viru
rsv
infect
recogn
rigi
known
caus
bronchiol
even
pneumonia
summari
report
rigi
rna
aptam
strong
tendenc
stimul
express
block
viral
replic
studi
increas
efficaci
stabil
rigi
aptam
well
develop
cellular
deliveri
tool
necessari
supplementari
data
avail
nar
onlin
supplementari
figur
supplementari
method
supplementari
refer
fund
open
access
charg
posco
research
fund
korea
healthcar
technolog
r
project
ministri
health
welfar
famili
affair
jyy
bio
r
program
nrf
korea
jyy
region
core
research
program
korean
ministri
educ
scienc
technolog
jyy
global
research
program
nation
research
foundat
korea
grant
number
bho
epb
center
grant
number
bhk
conflict
interest
statement
none
declar
